1-3 of 3
J. Rivière
Close
Sort by
Journal Articles

Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT

Clinical Trials & Observations
C. Schuetz, J. Gerke, M. Ege, J. Walter, M. Kusters, A. Worth, J. A. Kanakry, D. Dimitrova, B. Wolska-Kuśnierz, K. Chen, E. Unal, M. Karakukcu, O. Pashchenko, J. Leiding, T. Kawai, P. J. Amrolia, D. Berghuis, J. Buechner, D. Buchbinder, M. J. Cowan, A. R. Gennery, T. Güngör, J. Heimall, M. Miano, I. Meyts, E. C. Morris, J. Rivière, S. O. Sharapova, P. J. Shaw, M. Slatter, M. Honig, P. Veys, A. Fischer, M. Cavazzana, D. Moshous, A. Schulz, M. H. Albert, J. M. Puck, A. C. Lankester, L. D. Notarangelo, B. Neven
Journal: Blood
Blood (2023) 141 (7): 713–724.
https://doi.org/10.1182/blood.2022017667
Published: 2023
Includes: Supplemental data
Journal Articles

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Clinical Trials & Observations
Richard A. Larson, Brian J. Druker, Francois Guilhot, Stephen G. O'Brien, Gilles J. Riviere, Tillmann Krahnke, Insa Gathmann, Yanfeng Wang
Journal: Blood
Blood (2008) 111 (8): 4022–4028.
https://doi.org/10.1182/blood-2007-10-116475
Published: 2008
Includes: Supplemental data
Journal Articles

Correlation of Pharmacokinetic Data with Cytogenetic and Molecular Response in Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib - An Analysis of IRIS Study Data.

Richard A. Larson, MD, Brian J. Druker, MD, Francois Guilhot, MD, Stephen G. O’Brien, MBChB, PhD, Insa Gathmann, MS, Gilles J. Riviere, PhD, Charlene So, PharmD, Yanfeng Wang, PhD, on Behalf of the IRIS Study Group
Journal: Blood
Blood (2006) 108 (11): 429.
https://doi.org/10.1182/blood.V108.11.429.429
Published: 2006